H.R. 7630 · 117th Congress
Childhood Cancer STAR Reauthorization Act of 2022
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
109 cosponsors · 76 D, 33 R
3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act
What it does: CRS summary · Introduced in House · Apr 28, 2022
Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act
This bill reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Childhood Cancer STAR Reauthorization Act of 2022
Also known as: Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022
Latest action (Apr 29, 2022): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Apr 28, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.